Page 4 - Demo

• Phase I study of multisite stereotactic body radiotherapy plus nivolumab and urelumab or nivolumab and cabiralizumab in patients with advanced solid tumors
• Clinical response to tumor infiltrating lymphocytes in stage 4 NSCLC correlates with neoantigen-specificity: A phase I trial
Imaging Technologies
鄭澄意
何宗穎-林口長庚紀念醫院
• ImmunoPET for Whole Body Imaging of Immune Cell Subsets
• Flexible Copper-64-nanoparticle-based cell labeling system allows for in vivo tracking of adoptively transferred T-cells by PET/CT
............. 04
............. 04
............. 04
TOPIC
SESSION
MODERATOR
SPEAKER
TOPIC
6/21 DAY2
SESSION
MODERATOR SPEAKER TOPIC
SESSION
MODERATOR SPEAKER TOPIC
SPEAKER
TOPIC SESSION
SPEAKER
TOPIC SESSION MODERATOR
Technology for Engineering Exosomes in Immunotherapy
張文震
James Lai (賴志遠)-University of Washington
• Improving Immunotherapies via Smart Polymer Reagents
............. 04
............. 04
............. 04
Autoimmunity, Toxicity, Clinical Management and Cancer Immunotherapy
劉俊煌
許秉寧-臺大醫學院
• Clinical Considerations of Immune-Related Adverse Events
• Management of Complex IO Toxicity
• Immune checkpoint inhibitor therapy in patients with preexisting autoimmune disease
郭家榮-林口長庚紀念醫院
• Immune checkpoint inhibitor therapy in patients with
preexisting inflammatory bowel disease
Special Lecture
陳三奇-臺北榮民總醫院
• Antigen-Specific Cancer Immunotherapy
............. 04
............. 04
............. 04
............. 04
04
............. 04
............. 04 A Tale of Two Brain Tumors: Primary versus Metastatic CNS
Tumors
魏國珍
............. 04
5
.............